Q4 2023 Holdings
Filed 2024-02-14 | 15 holdings | $254.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Alpine Immune Sciences Inc(NVLSEUR) | COM | 02083G100 | $72.7M | 3,813,926 | 28.6% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $47.9M | 2,110,401 | 18.8% |
| Merus N V | COM | N5749R100 | $31.2M | 1,135,225 | 12.3% |
| Tscan Therapeutics Inc(TCRX) | COM | 89854M101 | $30.5M | 5,224,600 | 12.0% |
| C4 Therapeutics Inc(CCCC) | COM STK | 12529R107 | $17.7M | 3,134,396 | 7.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $15.6M | 2,956,918 | 6.1% |
| Autolus Therapeutics PLC(AUTL) | SPON ADS | 05280R100 | $12.0M | 1,858,409 | 4.7% |
| GH Research PLC(GHRS) | ORDINARY SHARES | G3855L106 | $10.7M | 1,838,617 | 4.2% |
| Kinnate Biopharma Inc | COM | 49705R105 | $4.7M | 1,997,006 | 1.9% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $4.1M | 235,787 | 1.6% |
| Theseus Pharmaceuticals Inc | COM | 88369M101 | $2.8M | 702,415 | 1.1% |
| Pieris Pharmaceuticals Inc | COM | 720795103 | $1.8M | 9,775,849 | 0.7% |
| Bionomics Limited(BNOXN) | ADS | 09063M205 | $1.2M | 824,305 | 0.5% |
| Nektar Therapeutics(NKTREUR) | COM | 640268108 | $1.1M | 1,929,198 | 0.4% |
| Passage BIO Inc | COM | 702712100 | $383.0K | 379,159 | 0.2% |